Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
McKesson
Mallinckrodt
Healthtrust
Dow
Farmers Insurance
Cipla
QuintilesIMS

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065430

« Back to Dashboard

NDA 065430 describes CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER profile page.

The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for 065430
Tradename:CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Applicant:B Braun
Ingredient:cefotetan disodium
Patents:0
Pharmacology for NDA: 065430
Ingredient-typeCephalosporins
Medical Subject Heading (MeSH) Categories for 065430
Suppliers and Packaging for NDA: 065430
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER cefotetan disodium INJECTABLE;INJECTION 065430 NDA B. Braun Medical Inc. 0264-3173 N 0264-3173-11
CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER cefotetan disodium INJECTABLE;INJECTION 065430 NDA B. Braun Medical Inc. 0264-3175 N 0264-3175-11

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Aug 9, 2007TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Aug 9, 2007TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Argus Health
UBS
Julphar
Medtronic
QuintilesIMS
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.